The Federal Trade Commission in the US is planning to sue ... drugs, the three largest PBMs were able to generate $1.6 billion in extra revenue over three years, according to the FTC.

Pharmacy benefit managers (PBMs) are coming under increased public scrutiny for their role in the healthcare industry. Last month the FTC ... drug pricing. Which is seemingly in preparation to sue ...

The FTC will reportedly sue a group of PBMs for ... debate over pharmacy benefits managers could mean significant changes for how consumers get their drugs — and how much they pay.

Longstanding claims that one of the reasons for high drug ... management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission ...

Debtors should carefully consider the impact of these contingencies in evaluating whether noncompete clauses survive ...

insurance companies and pharmacy benefit managers use noncompete agreements to prevent former employees from sharing proprietary information with competitors. Prior to the FTC's rule, noncompete ...

The Federal Trade Commission (FTC) recently finalized its Rule on the Use of Consumer Reviews and Testimonials (Rule) to combat fake reviews ...

In its comment, the FTC supports ... that discourage generic drug insurance reimbursement, as revealed in the Commission’s Interim Staff Report on Pharmacy Benefit Managers, undermine goals ...

Resolution in the ongoing antitrust trial over Kroger Co.’s planned $24.6 billion merger with Albertsons Cos. Inc. could ...

While Cuban's cost-plus model for generic drugs is ... benefit manager, or PBM, industry. The problem of rising drug prices and PBM profits has even driven some employees to sue for better coverage.

RELATED: FTC votes to ban noncompete agreements but faces legal challenges amid controversy The agreements prohibit employees from taking a job with a rival company or starting a competing ...